Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Platzer, B; Richter, S; Kneidinger, D; Waltenberger, D; Woisetschläger, M; Strobl, H.
Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells.
J Immunol. 2009; 183(1):66-74 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar


Autor/innen der Med Uni Graz:
Strobl Herbert

Dimensions Citations:

Plum Analytics:
The transcription factor aryl hydrocarbon receptor (AhR) represents a promising therapeutic target in allergy and autoimmunity. AhR signaling induced by the newly described ligand VAF347 inhibits allergic lung inflammation as well as suppresses pancreatic islet allograft rejection. These effects are likely mediated via alterations in dendritic cell (DC) function. Moreover, VAF347 induces tolerogenic DCs. Langerhans cells (LCs) are immediate targets of exogenous AhR ligands at epithelial surfaces; how they respond to AhR ligands remained undefined. We studied AhR expression and function in human LCs and myelopoietic cell subsets using a lineage differentiation and gene transduction model of human CD34(+) hematopoietic progenitors. We found that AhR is highly regulated during myeloid subset differentiation. LCs expressed highest AhR levels followed by monocytes. Conversely, neutrophil granulocytes lacked AhR expression. AhR ligands including VAF347 arrested the differentiation of monocytes and LCs at an early precursor cell stage, whereas progenitor cell expansion or granulopoiesis remained unimpaired. AhR expression was coregulated with the transcription factor PU.1 during myeloid subset differentiation. VAF347 inhibited PU.1 induction during initial monocytic differentiation, and ectopic PU.1 restored monocyte and LC generation in the presence of this compound. AhR ligands failed to interfere with cytokine receptor signaling during LC differentiation and failed to impair LC activation/maturation. VAF347-mediated antiproliferative effect on precursors undergoing LC lineage differentiation occurred in a clinically applicable serum-free culture model and was not accompanied by apoptosis induction. In conclusion, AhR agonist signaling interferes with transcriptional processes leading to monocyte/DC lineage commitment of human myeloid progenitor cells.
Find related publications in this database (using NLM MeSH Indexing)
Cell Differentiation - drug effects Cell Differentiation - genetics Cell Differentiation - immunology
Cell Lineage - drug effects Cell Lineage - genetics Cell Lineage - immunology
Cell Proliferation - drug effects
Cells, Cultured -
Growth Inhibitors - pharmacology Growth Inhibitors - physiology
Humans -
K562 Cells -
Langerhans Cells - cytology Langerhans Cells - immunology Langerhans Cells - metabolism
Monocytes - cytology Monocytes - immunology Monocytes - metabolism
Myeloid Progenitor Cells - cytology Myeloid Progenitor Cells - immunology Myeloid Progenitor Cells - metabolism
Pyrimidines - pharmacology
Receptors, Aryl Hydrocarbon - agonists Receptors, Aryl Hydrocarbon - metabolism Receptors, Aryl Hydrocarbon - physiology
Signal Transduction - drug effects Signal Transduction - genetics Signal Transduction - immunology
Transcription, Genetic - drug effects Transcription, Genetic - immunology

© Meduni Graz Impressum